Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0270 Transporter Info | ||||
Gene Name | SLC30A10 | ||||
Transporter Name | Zinc transporter 10 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Colon cancer |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg22146252) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.21E+00 | Statistic Test | p-value: 1.10E-03; Z-score: 1.89E+00 | ||
Methylation in Case |
4.37E-01 (Median) | Methylation in Control | 3.63E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg22048683) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 5.70E-08; Z-score: -1.62E+00 | ||
Methylation in Case |
4.22E-01 (Median) | Methylation in Control | 4.74E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg03993463) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 2.77E-05; Z-score: -1.93E+00 | ||
Methylation in Case |
7.42E-01 (Median) | Methylation in Control | 8.04E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
TSS200 (cg06236276) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 8.05E-04; Z-score: 1.11E+00 | ||
Methylation in Case |
7.01E-01 (Median) | Methylation in Control | 6.48E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg20979061) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.23E+00 | Statistic Test | p-value: 1.58E-06; Z-score: 2.64E+00 | ||
Methylation in Case |
6.38E-01 (Median) | Methylation in Control | 5.19E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC30A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg25214305) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.31E+00 | Statistic Test | p-value: 2.28E-06; Z-score: -3.25E+00 | ||
Methylation in Case |
5.64E-01 (Median) | Methylation in Control | 7.38E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC30A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg20241270) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.23E+00 | Statistic Test | p-value: 4.33E-06; Z-score: -4.30E+00 | ||
Methylation in Case |
6.66E-01 (Median) | Methylation in Control | 8.17E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC30A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg16099210) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 4.03E+00 | Statistic Test | p-value: 2.22E-05; Z-score: 5.50E+00 | ||
Methylation in Case |
4.00E-01 (Median) | Methylation in Control | 9.94E-02 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC30A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg03700302) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 4.10E-05; Z-score: -3.91E+00 | ||
Methylation in Case |
5.84E-01 (Median) | Methylation in Control | 7.01E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC30A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg01206944) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.15E+00 | Statistic Test | p-value: 6.08E-04; Z-score: -6.98E-01 | ||
Methylation in Case |
3.29E-01 (Median) | Methylation in Control | 3.80E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC30A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg26840162) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 9.19E-04; Z-score: -1.38E+00 | ||
Methylation in Case |
8.38E-01 (Median) | Methylation in Control | 8.65E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
5'UTR (cg02821501) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 2.27E-05; Z-score: 5.23E-01 | ||
Methylation in Case |
4.55E-02 (Median) | Methylation in Control | 4.03E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
TSS1500 (cg00755448) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.25E+00 | Statistic Test | p-value: 1.48E-15; Z-score: 1.42E+00 | ||
Methylation in Case |
1.76E-01 (Median) | Methylation in Control | 1.40E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
TSS1500 (cg02136132) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.68E+00 | Statistic Test | p-value: 2.65E-13; Z-score: 2.00E+00 | ||
Methylation in Case |
1.39E-01 (Median) | Methylation in Control | 8.28E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
TSS1500 (cg00748432) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.26E+00 | Statistic Test | p-value: 7.04E-13; Z-score: -2.04E+00 | ||
Methylation in Case |
3.55E-01 (Median) | Methylation in Control | 4.48E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
TSS1500 (cg00727912) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.24E+00 | Statistic Test | p-value: 2.52E-12; Z-score: -1.81E+00 | ||
Methylation in Case |
3.14E-01 (Median) | Methylation in Control | 3.88E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC30A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
TSS1500 (cg00995065) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 2.02E-03; Z-score: -1.50E-01 | ||
Methylation in Case |
6.95E-01 (Median) | Methylation in Control | 7.03E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC30A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
TSS1500 (cg13285458) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 3.71E-02; Z-score: -3.53E-01 | ||
Methylation in Case |
4.57E-02 (Median) | Methylation in Control | 5.03E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC30A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
Body (cg26313337) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 6.15E-12; Z-score: -1.61E+00 | ||
Methylation in Case |
6.58E-01 (Median) | Methylation in Control | 7.15E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC30A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
Body (cg16163535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.16E+00 | Statistic Test | p-value: 3.65E-03; Z-score: -1.08E+00 | ||
Methylation in Case |
7.64E-01 (Median) | Methylation in Control | 8.87E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC30A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
Body (cg02501120) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 3.46E-02; Z-score: -2.26E-01 | ||
Methylation in Case |
5.10E-02 (Median) | Methylation in Control | 5.60E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC30A10 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
3'UTR (cg13711063) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 2.48E-09; Z-score: -1.50E+00 | ||
Methylation in Case |
7.77E-01 (Median) | Methylation in Control | 8.41E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A10 in prostate cancer | [ 3 ] | |||
Location |
5'UTR (cg09552652) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 1.51E-02; Z-score: 2.44E+00 | ||
Methylation in Case |
9.04E-01 (Median) | Methylation in Control | 8.13E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A10 in prostate cancer | [ 3 ] | |||
Location |
TSS1500 (cg02515800) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.50E+00 | Statistic Test | p-value: 2.32E-02; Z-score: -1.98E+00 | ||
Methylation in Case |
1.87E-01 (Median) | Methylation in Control | 2.80E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A10 in prostate cancer | [ 3 ] | |||
Location |
TSS200 (cg20780337) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.57E+00 | Statistic Test | p-value: 1.18E-02; Z-score: 4.03E+00 | ||
Methylation in Case |
7.08E-02 (Median) | Methylation in Control | 4.50E-02 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A10 in prostate cancer | [ 3 ] | |||
Location |
1stExon (cg06723421) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 2.36E-02; Z-score: 2.73E+00 | ||
Methylation in Case |
8.87E-01 (Median) | Methylation in Control | 8.30E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A10 in prostate cancer | [ 3 ] | |||
Location |
Body (cg12565580) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.26E+00 | Statistic Test | p-value: 3.06E-02; Z-score: -2.34E+00 | ||
Methylation in Case |
6.32E-01 (Median) | Methylation in Control | 7.95E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A10 in bladder cancer | [ 4 ] | |||
Location |
TSS1500 (cg05155775) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.61E+00 | Statistic Test | p-value: 1.64E-10; Z-score: -7.71E+00 | ||
Methylation in Case |
4.26E-01 (Median) | Methylation in Control | 6.87E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A10 in bladder cancer | [ 4 ] | |||
Location |
TSS1500 (cg19313402) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.61E+00 | Statistic Test | p-value: 6.01E-08; Z-score: -6.02E+00 | ||
Methylation in Case |
3.18E-01 (Median) | Methylation in Control | 5.12E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A10 in bladder cancer | [ 4 ] | |||
Location |
TSS1500 (cg21648401) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.87E+00 | Statistic Test | p-value: 2.95E-07; Z-score: -6.14E+00 | ||
Methylation in Case |
3.09E-01 (Median) | Methylation in Control | 5.78E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A10 in bladder cancer | [ 4 ] | |||
Location |
TSS1500 (cg27295373) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.47E+00 | Statistic Test | p-value: 2.70E-06; Z-score: -4.50E+00 | ||
Methylation in Case |
2.96E-01 (Median) | Methylation in Control | 4.35E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A10 in bladder cancer | [ 4 ] | |||
Location |
TSS200 (cg12355180) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.39E+00 | Statistic Test | p-value: 2.12E-02; Z-score: -3.20E+00 | ||
Methylation in Case |
1.08E-01 (Median) | Methylation in Control | 1.51E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC30A10 in bladder cancer | [ 4 ] | |||
Location |
TSS200 (cg25841634) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.38E+00 | Statistic Test | p-value: 2.90E-02; Z-score: -1.29E+00 | ||
Methylation in Case |
6.93E-02 (Median) | Methylation in Control | 9.58E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC30A10 in bladder cancer | [ 4 ] | |||
Location |
Body (cg16814688) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.86E+00 | Statistic Test | p-value: 5.50E-11; Z-score: -9.55E+00 | ||
Methylation in Case |
4.24E-01 (Median) | Methylation in Control | 7.91E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC30A10 in bladder cancer | [ 4 ] | |||
Location |
Body (cg07005353) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.19E+00 | Statistic Test | p-value: 7.62E-06; Z-score: -7.12E+00 | ||
Methylation in Case |
7.25E-01 (Median) | Methylation in Control | 8.62E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC30A10 in bladder cancer | [ 4 ] | |||
Location |
Body (cg27629095) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.42E+00 | Statistic Test | p-value: 1.83E-04; Z-score: -3.97E+00 | ||
Methylation in Case |
5.38E-01 (Median) | Methylation in Control | 7.63E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC30A10 in bladder cancer | [ 4 ] | |||
Location |
Body (cg07948194) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 5.26E-03; Z-score: -2.85E+00 | ||
Methylation in Case |
8.59E-01 (Median) | Methylation in Control | 8.88E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
14 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A10 in breast cancer | [ 5 ] | |||
Location |
TSS1500 (cg05155775) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 1.31E-10; Z-score: -2.32E+00 | ||
Methylation in Case |
6.86E-01 (Median) | Methylation in Control | 7.74E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A10 in breast cancer | [ 5 ] | |||
Location |
TSS1500 (cg02557906) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 5.16E-07; Z-score: -1.37E+00 | ||
Methylation in Case |
6.05E-01 (Median) | Methylation in Control | 6.68E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A10 in breast cancer | [ 5 ] | |||
Location |
TSS1500 (cg21648401) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 1.63E-06; Z-score: -9.97E-01 | ||
Methylation in Case |
6.61E-01 (Median) | Methylation in Control | 7.05E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A10 in breast cancer | [ 5 ] | |||
Location |
TSS200 (cg12355180) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 2.42E-06; Z-score: 5.95E-01 | ||
Methylation in Case |
1.79E-01 (Median) | Methylation in Control | 1.58E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A10 in breast cancer | [ 5 ] | |||
Location |
TSS200 (cg25841634) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 1.44E-02; Z-score: 1.39E-01 | ||
Methylation in Case |
7.51E-02 (Median) | Methylation in Control | 7.02E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC30A10 in breast cancer | [ 5 ] | |||
Location |
1stExon (cg26685195) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.83E+00 | Statistic Test | p-value: 2.16E-13; Z-score: 2.75E+00 | ||
Methylation in Case |
2.55E-01 (Median) | Methylation in Control | 1.40E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC30A10 in breast cancer | [ 5 ] | |||
Location |
1stExon (cg14848594) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.82E+00 | Statistic Test | p-value: 2.31E-12; Z-score: 3.21E+00 | ||
Methylation in Case |
2.52E-01 (Median) | Methylation in Control | 1.39E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC30A10 in breast cancer | [ 5 ] | |||
Location |
1stExon (cg24933645) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.04E+00 | Statistic Test | p-value: 1.18E-10; Z-score: 2.31E+00 | ||
Methylation in Case |
2.17E-01 (Median) | Methylation in Control | 1.07E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC30A10 in breast cancer | [ 5 ] | |||
Location |
1stExon (cg17721710) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.64E+00 | Statistic Test | p-value: 1.40E-09; Z-score: 1.79E+00 | ||
Methylation in Case |
1.28E-01 (Median) | Methylation in Control | 4.86E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC30A10 in breast cancer | [ 5 ] | |||
Location |
1stExon (cg24396691) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.43E+00 | Statistic Test | p-value: 2.05E-06; Z-score: 9.28E-01 | ||
Methylation in Case |
5.34E-02 (Median) | Methylation in Control | 2.20E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC30A10 in breast cancer | [ 5 ] | |||
Location |
Body (cg16814688) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 1.34E-06; Z-score: -1.40E+00 | ||
Methylation in Case |
6.67E-01 (Median) | Methylation in Control | 7.37E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC30A10 in breast cancer | [ 5 ] | |||
Location |
Body (cg07005353) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 1.06E-05; Z-score: -8.60E-01 | ||
Methylation in Case |
7.75E-01 (Median) | Methylation in Control | 8.10E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC30A10 in breast cancer | [ 5 ] | |||
Location |
Body (cg27629095) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 5.99E-04; Z-score: -6.13E-01 | ||
Methylation in Case |
6.15E-01 (Median) | Methylation in Control | 7.02E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 14 |
Methylation of SLC30A10 in breast cancer | [ 5 ] | |||
Location |
Body (cg07948194) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 9.91E-03; Z-score: -2.88E-01 | ||
Methylation in Case |
8.47E-01 (Median) | Methylation in Control | 8.89E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A10 in clear cell renal cell carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg19313402) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.15E+00 | Statistic Test | p-value: 8.51E-10; Z-score: 2.42E+00 | ||
Methylation in Case |
7.68E-01 (Median) | Methylation in Control | 6.67E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A10 in clear cell renal cell carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg27295373) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 2.11E-06; Z-score: 3.78E+00 | ||
Methylation in Case |
6.53E-01 (Median) | Methylation in Control | 5.33E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A10 in clear cell renal cell carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg05155775) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.79E-03; Z-score: -2.12E-01 | ||
Methylation in Case |
8.74E-01 (Median) | Methylation in Control | 8.79E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A10 in clear cell renal cell carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg21648401) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 7.06E-03; Z-score: 1.86E+00 | ||
Methylation in Case |
8.15E-01 (Median) | Methylation in Control | 7.23E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A10 in clear cell renal cell carcinoma | [ 6 ] | |||
Location |
TSS200 (cg25841634) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 5.76E-03; Z-score: 6.24E-01 | ||
Methylation in Case |
4.42E-02 (Median) | Methylation in Control | 3.88E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC30A10 in clear cell renal cell carcinoma | [ 6 ] | |||
Location |
1stExon (cg26685195) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.66E+00 | Statistic Test | p-value: 1.31E-06; Z-score: 3.15E+00 | ||
Methylation in Case |
2.31E-01 (Median) | Methylation in Control | 1.39E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC30A10 in clear cell renal cell carcinoma | [ 6 ] | |||
Location |
1stExon (cg24933645) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.39E+00 | Statistic Test | p-value: 5.40E-06; Z-score: 3.48E+00 | ||
Methylation in Case |
1.28E-01 (Median) | Methylation in Control | 5.35E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC30A10 in clear cell renal cell carcinoma | [ 6 ] | |||
Location |
1stExon (cg17721710) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.48E+00 | Statistic Test | p-value: 5.44E-05; Z-score: 2.69E+00 | ||
Methylation in Case |
4.46E-02 (Median) | Methylation in Control | 3.01E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC30A10 in clear cell renal cell carcinoma | [ 6 ] | |||
Location |
1stExon (cg14848594) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.29E+00 | Statistic Test | p-value: 7.72E-05; Z-score: 1.51E+00 | ||
Methylation in Case |
1.68E-01 (Median) | Methylation in Control | 1.30E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC30A10 in clear cell renal cell carcinoma | [ 6 ] | |||
Location |
1stExon (cg24396691) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.08E+00 | Statistic Test | p-value: 1.39E-04; Z-score: 2.04E+00 | ||
Methylation in Case |
4.65E-02 (Median) | Methylation in Control | 2.23E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC30A10 in clear cell renal cell carcinoma | [ 6 ] | |||
Location |
Body (cg07948194) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 5.08E-03; Z-score: -7.55E-01 | ||
Methylation in Case |
9.74E-01 (Median) | Methylation in Control | 9.79E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A10 in colorectal cancer | [ 7 ] | |||
Location |
TSS1500 (cg19313402) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 4.67E-03; Z-score: 1.14E+00 | ||
Methylation in Case |
7.07E-01 (Median) | Methylation in Control | 6.12E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A10 in colorectal cancer | [ 7 ] | |||
Location |
TSS1500 (cg27295373) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 5.62E-03; Z-score: 1.11E+00 | ||
Methylation in Case |
6.91E-01 (Median) | Methylation in Control | 6.30E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A10 in colorectal cancer | [ 7 ] | |||
Location |
TSS200 (cg12355180) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 4.85E-07; Z-score: 1.23E+00 | ||
Methylation in Case |
2.21E-01 (Median) | Methylation in Control | 1.89E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A10 in colorectal cancer | [ 7 ] | |||
Location |
TSS200 (cg25841634) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.36E+00 | Statistic Test | p-value: 6.44E-06; Z-score: 1.33E+00 | ||
Methylation in Case |
5.39E-02 (Median) | Methylation in Control | 3.95E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A10 in colorectal cancer | [ 7 ] | |||
Location |
1stExon (cg14848594) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.29E+00 | Statistic Test | p-value: 1.15E-19; Z-score: 4.95E+00 | ||
Methylation in Case |
5.85E-01 (Median) | Methylation in Control | 2.56E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC30A10 in colorectal cancer | [ 7 ] | |||
Location |
1stExon (cg26685195) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.27E+00 | Statistic Test | p-value: 1.60E-16; Z-score: 4.28E+00 | ||
Methylation in Case |
6.09E-01 (Median) | Methylation in Control | 2.68E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC30A10 in colorectal cancer | [ 7 ] | |||
Location |
1stExon (cg24933645) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 4.88E+00 | Statistic Test | p-value: 2.84E-12; Z-score: 5.37E+00 | ||
Methylation in Case |
3.08E-01 (Median) | Methylation in Control | 6.30E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC30A10 in colorectal cancer | [ 7 ] | |||
Location |
1stExon (cg17721710) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 8.90E+00 | Statistic Test | p-value: 4.20E-12; Z-score: 1.63E+01 | ||
Methylation in Case |
3.35E-01 (Median) | Methylation in Control | 3.77E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC30A10 in colorectal cancer | [ 7 ] | |||
Location |
1stExon (cg24396691) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 7.35E+00 | Statistic Test | p-value: 5.34E-12; Z-score: 9.26E+00 | ||
Methylation in Case |
1.73E-01 (Median) | Methylation in Control | 2.36E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Hypermethylation of SLC30A10 in colorectal cancer | [ 15 ] | |||
Location |
Promoter | ||||
Epigenetic Type |
Methylation | Experiment Method | MeDIP-Chip | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Depression |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A10 in depression | [ 8 ] | |||
Location |
TSS1500 (cg21648401) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 3.25E-02; Z-score: 4.57E-01 | ||
Methylation in Case |
6.42E-01 (Median) | Methylation in Control | 6.23E-01 (Median) | ||
Studied Phenotype |
Depression [ ICD-11: 6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
19 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
TSS1500 (cg09715906) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.47E+00 | Statistic Test | p-value: 2.61E-14; Z-score: -2.42E+00 | ||
Methylation in Case |
5.35E-01 (Median) | Methylation in Control | 7.84E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
TSS1500 (cg27295373) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.26E+00 | Statistic Test | p-value: 1.03E-04; Z-score: -1.18E+00 | ||
Methylation in Case |
3.56E-01 (Median) | Methylation in Control | 4.48E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
TSS1500 (cg19313402) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.28E+00 | Statistic Test | p-value: 3.71E-04; Z-score: -1.16E+00 | ||
Methylation in Case |
3.65E-01 (Median) | Methylation in Control | 4.65E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
TSS1500 (cg02557906) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.38E+00 | Statistic Test | p-value: 6.64E-04; Z-score: -1.21E+00 | ||
Methylation in Case |
3.32E-01 (Median) | Methylation in Control | 4.59E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
TSS200 (cg11207307) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.98E+00 | Statistic Test | p-value: 7.66E-19; Z-score: 3.34E+00 | ||
Methylation in Case |
5.70E-01 (Median) | Methylation in Control | 2.87E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
TSS200 (cg25841634) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.25E+00 | Statistic Test | p-value: 2.75E-05; Z-score: -8.17E-01 | ||
Methylation in Case |
4.36E-02 (Median) | Methylation in Control | 5.45E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
1stExon (cg26685195) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.37E+00 | Statistic Test | p-value: 2.39E-09; Z-score: -1.27E+00 | ||
Methylation in Case |
1.03E-01 (Median) | Methylation in Control | 1.42E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
1stExon (cg24933645) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.71E+00 | Statistic Test | p-value: 1.33E-07; Z-score: -9.90E-01 | ||
Methylation in Case |
4.90E-02 (Median) | Methylation in Control | 8.37E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
1stExon (cg14848594) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.25E+00 | Statistic Test | p-value: 2.42E-07; Z-score: -1.11E+00 | ||
Methylation in Case |
1.05E-01 (Median) | Methylation in Control | 1.32E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
1stExon (cg24396691) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.50E+00 | Statistic Test | p-value: 4.97E-05; Z-score: -6.88E-01 | ||
Methylation in Case |
2.13E-02 (Median) | Methylation in Control | 3.20E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
1stExon (cg17721710) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.37E+00 | Statistic Test | p-value: 9.29E-03; Z-score: -5.19E-01 | ||
Methylation in Case |
3.20E-02 (Median) | Methylation in Control | 4.37E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
Body (cg13096859) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.64E+00 | Statistic Test | p-value: 2.18E-21; Z-score: -1.12E+01 | ||
Methylation in Case |
5.02E-01 (Median) | Methylation in Control | 8.22E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
Body (cg12860764) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.65E+00 | Statistic Test | p-value: 1.16E-19; Z-score: -7.99E+00 | ||
Methylation in Case |
4.76E-01 (Median) | Methylation in Control | 7.82E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 14 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
Body (cg11112833) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.67E+00 | Statistic Test | p-value: 3.19E-18; Z-score: -1.12E+01 | ||
Methylation in Case |
5.17E-01 (Median) | Methylation in Control | 8.63E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 15 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
Body (cg05603680) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.56E+00 | Statistic Test | p-value: 2.31E-14; Z-score: -4.35E+00 | ||
Methylation in Case |
3.88E-01 (Median) | Methylation in Control | 6.05E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 16 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
Body (cg12223004) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.88E+00 | Statistic Test | p-value: 4.60E-14; Z-score: -5.09E+00 | ||
Methylation in Case |
3.22E-01 (Median) | Methylation in Control | 6.04E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 17 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
Body (cg01266985) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 1.56E-12; Z-score: 1.26E+00 | ||
Methylation in Case |
6.98E-01 (Median) | Methylation in Control | 6.40E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 18 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
Body (cg07005353) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.29E+00 | Statistic Test | p-value: 2.64E-06; Z-score: -1.11E+00 | ||
Methylation in Case |
4.42E-01 (Median) | Methylation in Control | 5.69E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 19 |
Methylation of SLC30A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
3'UTR (cg15149374) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.41E+00 | Statistic Test | p-value: 2.67E-15; Z-score: -4.74E+00 | ||
Methylation in Case |
5.25E-01 (Median) | Methylation in Control | 7.40E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
14 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A10 in HIV infection | [ 10 ] | |||
Location |
TSS1500 (cg05155775) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 3.03E-05; Z-score: 8.65E-01 | ||
Methylation in Case |
7.99E-01 (Median) | Methylation in Control | 7.69E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A10 in HIV infection | [ 10 ] | |||
Location |
TSS1500 (cg19313402) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 1.13E-04; Z-score: 1.17E+00 | ||
Methylation in Case |
7.17E-01 (Median) | Methylation in Control | 6.60E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A10 in HIV infection | [ 10 ] | |||
Location |
TSS1500 (cg21648401) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 2.33E-03; Z-score: 4.61E-01 | ||
Methylation in Case |
7.61E-01 (Median) | Methylation in Control | 7.37E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A10 in HIV infection | [ 10 ] | |||
Location |
TSS1500 (cg02557906) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 2.29E-02; Z-score: 4.98E-01 | ||
Methylation in Case |
7.25E-01 (Median) | Methylation in Control | 6.98E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A10 in HIV infection | [ 10 ] | |||
Location |
TSS1500 (cg27295373) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 3.35E-02; Z-score: 6.47E-01 | ||
Methylation in Case |
6.05E-01 (Median) | Methylation in Control | 5.65E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC30A10 in HIV infection | [ 10 ] | |||
Location |
TSS200 (cg12355180) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.30E+00 | Statistic Test | p-value: 4.20E-05; Z-score: 1.23E+00 | ||
Methylation in Case |
1.23E-01 (Median) | Methylation in Control | 9.42E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC30A10 in HIV infection | [ 10 ] | |||
Location |
TSS200 (cg25841634) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.41E+00 | Statistic Test | p-value: 9.18E-03; Z-score: 8.68E-01 | ||
Methylation in Case |
6.07E-02 (Median) | Methylation in Control | 4.30E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC30A10 in HIV infection | [ 10 ] | |||
Location |
1stExon (cg24933645) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.90E+00 | Statistic Test | p-value: 2.09E-05; Z-score: 3.01E+00 | ||
Methylation in Case |
1.72E-01 (Median) | Methylation in Control | 9.09E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC30A10 in HIV infection | [ 10 ] | |||
Location |
1stExon (cg17721710) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.41E+00 | Statistic Test | p-value: 2.16E-05; Z-score: 2.54E+00 | ||
Methylation in Case |
7.15E-02 (Median) | Methylation in Control | 2.96E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC30A10 in HIV infection | [ 10 ] | |||
Location |
1stExon (cg26685195) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.35E+00 | Statistic Test | p-value: 2.71E-05; Z-score: 1.52E+00 | ||
Methylation in Case |
1.76E-01 (Median) | Methylation in Control | 1.31E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC30A10 in HIV infection | [ 10 ] | |||
Location |
1stExon (cg24396691) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.36E+00 | Statistic Test | p-value: 4.15E-04; Z-score: 1.71E+00 | ||
Methylation in Case |
4.39E-02 (Median) | Methylation in Control | 1.86E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC30A10 in HIV infection | [ 10 ] | |||
Location |
1stExon (cg14848594) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.23E+00 | Statistic Test | p-value: 7.12E-04; Z-score: 1.12E+00 | ||
Methylation in Case |
1.60E-01 (Median) | Methylation in Control | 1.30E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC30A10 in HIV infection | [ 10 ] | |||
Location |
Body (cg27629095) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.11E+00 | Statistic Test | p-value: 1.08E-05; Z-score: -1.84E+00 | ||
Methylation in Case |
7.55E-01 (Median) | Methylation in Control | 8.40E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 14 |
Methylation of SLC30A10 in HIV infection | [ 10 ] | |||
Location |
Body (cg16814688) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 2.97E-02; Z-score: -8.30E-01 | ||
Methylation in Case |
7.87E-01 (Median) | Methylation in Control | 8.18E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A10 in lung adenocarcinoma | [ 11 ] | |||
Location |
TSS1500 (cg21648401) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 3.04E-04; Z-score: 2.15E+00 | ||
Methylation in Case |
7.34E-01 (Median) | Methylation in Control | 6.46E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A10 in lung adenocarcinoma | [ 11 ] | |||
Location |
TSS1500 (cg27295373) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 1.88E-03; Z-score: 1.90E+00 | ||
Methylation in Case |
6.43E-01 (Median) | Methylation in Control | 5.36E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A10 in lung adenocarcinoma | [ 11 ] | |||
Location |
TSS1500 (cg19313402) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.21E+00 | Statistic Test | p-value: 2.25E-02; Z-score: 2.78E+00 | ||
Methylation in Case |
7.28E-01 (Median) | Methylation in Control | 6.04E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A10 in lung adenocarcinoma | [ 11 ] | |||
Location |
TSS200 (cg12355180) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.54E+00 | Statistic Test | p-value: 1.33E-02; Z-score: 3.74E+00 | ||
Methylation in Case |
2.32E-01 (Median) | Methylation in Control | 1.51E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A10 in lung adenocarcinoma | [ 11 ] | |||
Location |
1stExon (cg24396691) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.68E+00 | Statistic Test | p-value: 2.62E-03; Z-score: 8.38E+00 | ||
Methylation in Case |
2.42E-01 (Median) | Methylation in Control | 6.57E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC30A10 in lung adenocarcinoma | [ 11 ] | |||
Location |
1stExon (cg24933645) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.27E+00 | Statistic Test | p-value: 3.13E-03; Z-score: 1.38E+01 | ||
Methylation in Case |
3.53E-01 (Median) | Methylation in Control | 1.55E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC30A10 in lung adenocarcinoma | [ 11 ] | |||
Location |
1stExon (cg26685195) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.79E+00 | Statistic Test | p-value: 4.08E-03; Z-score: 3.02E+00 | ||
Methylation in Case |
3.78E-01 (Median) | Methylation in Control | 2.12E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC30A10 in lung adenocarcinoma | [ 11 ] | |||
Location |
1stExon (cg14848594) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.83E+00 | Statistic Test | p-value: 9.81E-03; Z-score: 6.00E+00 | ||
Methylation in Case |
3.39E-01 (Median) | Methylation in Control | 1.85E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC30A10 in lung adenocarcinoma | [ 11 ] | |||
Location |
1stExon (cg17721710) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.39E+00 | Statistic Test | p-value: 1.47E-02; Z-score: 7.58E+00 | ||
Methylation in Case |
2.70E-01 (Median) | Methylation in Control | 7.96E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC30A10 in lung adenocarcinoma | [ 11 ] | |||
Location |
Body (cg16814688) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.11E+00 | Statistic Test | p-value: 4.28E-04; Z-score: -2.49E+00 | ||
Methylation in Case |
7.17E-01 (Median) | Methylation in Control | 7.93E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC30A10 in lung adenocarcinoma | [ 11 ] | |||
Location |
Body (cg27629095) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 1.30E-02; Z-score: -1.11E+00 | ||
Methylation in Case |
6.79E-01 (Median) | Methylation in Control | 7.34E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A10 in papillary thyroid cancer | [ 12 ] | |||
Location |
TSS1500 (cg19313402) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 1.31E-03; Z-score: 9.76E-01 | ||
Methylation in Case |
7.71E-01 (Median) | Methylation in Control | 7.30E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A10 in papillary thyroid cancer | [ 12 ] | |||
Location |
TSS1500 (cg27295373) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 3.16E-03; Z-score: 9.14E-01 | ||
Methylation in Case |
5.51E-01 (Median) | Methylation in Control | 5.06E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A10 in papillary thyroid cancer | [ 12 ] | |||
Location |
1stExon (cg17721710) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 3.53E-04; Z-score: 6.61E-01 | ||
Methylation in Case |
9.34E-02 (Median) | Methylation in Control | 8.33E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A10 in papillary thyroid cancer | [ 12 ] | |||
Location |
1stExon (cg24933645) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.15E+00 | Statistic Test | p-value: 8.88E-04; Z-score: 7.55E-01 | ||
Methylation in Case |
1.27E-01 (Median) | Methylation in Control | 1.11E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A10 in papillary thyroid cancer | [ 12 ] | |||
Location |
1stExon (cg24396691) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 2.66E-03; Z-score: 3.97E-01 | ||
Methylation in Case |
5.30E-02 (Median) | Methylation in Control | 4.75E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC30A10 in papillary thyroid cancer | [ 12 ] | |||
Location |
1stExon (cg26685195) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 3.99E-02; Z-score: 3.84E-01 | ||
Methylation in Case |
1.12E-01 (Median) | Methylation in Control | 1.04E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC30A10 in papillary thyroid cancer | [ 12 ] | |||
Location |
Body (cg16814688) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 2.37E-10; Z-score: -2.06E+00 | ||
Methylation in Case |
8.29E-01 (Median) | Methylation in Control | 8.85E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC30A10 in papillary thyroid cancer | [ 12 ] | |||
Location |
Body (cg27629095) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 3.97E-09; Z-score: -1.44E+00 | ||
Methylation in Case |
8.12E-01 (Median) | Methylation in Control | 8.59E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC30A10 in papillary thyroid cancer | [ 12 ] | |||
Location |
Body (cg07948194) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.84E-03; Z-score: -5.26E-01 | ||
Methylation in Case |
9.42E-01 (Median) | Methylation in Control | 9.47E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A10 in atypical teratoid rhabdoid tumor | [ 13 ] | |||
Location |
1stExon (cg14848594) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 4.23E+00 | Statistic Test | p-value: 5.25E-19; Z-score: 2.99E+00 | ||
Methylation in Case |
5.44E-01 (Median) | Methylation in Control | 1.29E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A10 in atypical teratoid rhabdoid tumor | [ 13 ] | |||
Location |
1stExon (cg17721710) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.21E+00 | Statistic Test | p-value: 8.36E-18; Z-score: -3.61E+00 | ||
Methylation in Case |
7.50E-01 (Median) | Methylation in Control | 9.08E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A10 in atypical teratoid rhabdoid tumor | [ 13 ] | |||
Location |
1stExon (cg24396691) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 1.24E-16; Z-score: -2.33E+00 | ||
Methylation in Case |
7.46E-01 (Median) | Methylation in Control | 8.32E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A10 in atypical teratoid rhabdoid tumor | [ 13 ] | |||
Location |
1stExon (cg24933645) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.55E+00 | Statistic Test | p-value: 3.84E-16; Z-score: 2.45E+00 | ||
Methylation in Case |
8.47E-01 (Median) | Methylation in Control | 5.46E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A10 in atypical teratoid rhabdoid tumor | [ 13 ] | |||
Location |
1stExon (cg26685195) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.47E+00 | Statistic Test | p-value: 5.63E-16; Z-score: -2.41E+00 | ||
Methylation in Case |
5.01E-01 (Median) | Methylation in Control | 7.36E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC30A10 in atypical teratoid rhabdoid tumor | [ 13 ] | |||
Location |
Body (cg07005353) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.53E+00 | Statistic Test | p-value: 3.23E-03; Z-score: -4.77E-01 | ||
Methylation in Case |
1.43E-01 (Median) | Methylation in Control | 2.19E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC30A10 in atypical teratoid rhabdoid tumor | [ 13 ] | |||
Location |
Body (cg07948194) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 5.06E-03; Z-score: 7.52E-01 | ||
Methylation in Case |
6.70E-01 (Median) | Methylation in Control | 6.06E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A10 in systemic lupus erythematosus | [ 14 ] | |||
Location |
1stExon (cg17721710) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 2.49E-02; Z-score: 9.81E-02 | ||
Methylation in Case |
5.22E-02 (Median) | Methylation in Control | 4.98E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Oligodendroglioma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypermethylation of SLC30A10 in oligodendroglioma than that in healthy individual | ||||
Studied Phenotype |
Oligodendroglioma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 8.32E-27; Fold-change: 0.25594477; Z-score: 2.648567995 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Lymphoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC30A10 in lymphoma than that in healthy individual | ||||
Studied Phenotype |
Lymphoma [ICD-11:2B30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 2.21E-11; Fold-change: 0.398873901; Z-score: 14.19373823 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
microRNA |
|||||
Unclear Phenotype |
36 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-129 directly targets SLC30A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-129 | miRNA Mature ID | miR-129-5p | ||
miRNA Sequence |
CUUUUUGCGGUCUGGGCUUGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 2 |
miR-1303 directly targets SLC30A10 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1303 | miRNA Mature ID | miR-1303 | ||
miRNA Sequence |
UUUAGAGACGGGGUCUUGCUCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 3 |
miR-1827 directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1827 | miRNA Mature ID | miR-1827 | ||
miRNA Sequence |
UGAGGCAGUAGAUUGAAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 4 |
miR-1910 directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1910 | miRNA Mature ID | miR-1910-3p | ||
miRNA Sequence |
GAGGCAGAAGCAGGAUGACA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 5 |
miR-26b directly targets SLC30A10 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-26b | miRNA Mature ID | miR-26b-5p | ||
miRNA Sequence |
UUCAAGUAAUUCAGGAUAGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human cervical cancer cell line (Hela) | ||||
Epigenetic Phenomenon 6 |
miR-29a directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-29a | miRNA Mature ID | miR-29a-3p | ||
miRNA Sequence |
UAGCACCAUCUGAAAUCGGUUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 7 |
miR-29b directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-29b | miRNA Mature ID | miR-29b-3p | ||
miRNA Sequence |
UAGCACCAUUUGAAAUCAGUGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 8 |
miR-29c directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-29c | miRNA Mature ID | miR-29c-3p | ||
miRNA Sequence |
UAGCACCAUUUGAAAUCGGUUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 9 |
miR-3189 directly targets SLC30A10 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3189 | miRNA Mature ID | miR-3189-3p | ||
miRNA Sequence |
CCCUUGGGUCUGAUGGGGUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 10 |
miR-335 directly targets SLC30A10 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-335 | miRNA Mature ID | miR-335-3p | ||
miRNA Sequence |
UUUUUCAUUAUUGCUCCUGACC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 11 |
miR-3612 directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3612 | miRNA Mature ID | miR-3612 | ||
miRNA Sequence |
AGGAGGCAUCUUGAGAAAUGGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 12 |
miR-3680 directly targets SLC30A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3680 | miRNA Mature ID | miR-3680-3p | ||
miRNA Sequence |
UUUUGCAUGACCCUGGGAGUAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 13 |
miR-3945 directly targets SLC30A10 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3945 | miRNA Mature ID | miR-3945 | ||
miRNA Sequence |
AGGGCAUAGGAGAGGGUUGAUAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 14 |
miR-4253 directly targets SLC30A10 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4253 | miRNA Mature ID | miR-4253 | ||
miRNA Sequence |
AGGGCAUGUCCAGGGGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 15 |
miR-4327 directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4327 | miRNA Mature ID | miR-4327 | ||
miRNA Sequence |
GGCUUGCAUGGGGGACUGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 16 |
miR-4424 directly targets SLC30A10 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4424 | miRNA Mature ID | miR-4424 | ||
miRNA Sequence |
AGAGUUAACUCAAAAUGGACUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 17 |
miR-450b directly targets SLC30A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-450b | miRNA Mature ID | miR-450b-5p | ||
miRNA Sequence |
UUUUGCAAUAUGUUCCUGAAUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 18 |
miR-4537 directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4537 | miRNA Mature ID | miR-4537 | ||
miRNA Sequence |
UGAGCCGAGCUGAGCUUAGCUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 19 |
miR-4539 directly targets SLC30A10 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4539 | miRNA Mature ID | miR-4539 | ||
miRNA Sequence |
GCUGAACUGGGCUGAGCUGGGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 20 |
miR-455 directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-455 | miRNA Mature ID | miR-455-3p | ||
miRNA Sequence |
GCAGUCCAUGGGCAUAUACAC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 21 |
miR-4695 directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4695 | miRNA Mature ID | miR-4695-5p | ||
miRNA Sequence |
CAGGAGGCAGUGGGCGAGCAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 22 |
miR-4724 directly targets SLC30A10 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4724 | miRNA Mature ID | miR-4724-5p | ||
miRNA Sequence |
AACUGAACCAGGAGUGAGCUUCG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 23 |
miR-507 directly targets SLC30A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-507 | miRNA Mature ID | miR-507 | ||
miRNA Sequence |
UUUUGCACCUUUUGGAGUGAA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 24 |
miR-526b directly targets SLC30A10 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-526b | miRNA Mature ID | miR-526b-5p | ||
miRNA Sequence |
CUCUUGAGGGAAGCACUUUCUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 25 |
miR-557 directly targets SLC30A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-557 | miRNA Mature ID | miR-557 | ||
miRNA Sequence |
GUUUGCACGGGUGGGCCUUGUCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 26 |
miR-5584 directly targets SLC30A10 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-5584 | miRNA Mature ID | miR-5584-3p | ||
miRNA Sequence |
UAGUUCUUCCCUUUGCCCAAUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 27 |
miR-5682 directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-5682 | miRNA Mature ID | miR-5682 | ||
miRNA Sequence |
GUAGCACCUUGCAGGAUAAGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 28 |
miR-635 directly targets SLC30A10 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-635 | miRNA Mature ID | miR-635 | ||
miRNA Sequence |
ACUUGGGCACUGAAACAAUGUCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 29 |
miR-6499 directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6499 | miRNA Mature ID | miR-6499-3p | ||
miRNA Sequence |
AGCAGUGUUUGUUUUGCCCACA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 30 |
miR-650 directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-650 | miRNA Mature ID | miR-650 | ||
miRNA Sequence |
AGGAGGCAGCGCUCUCAGGAC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 31 |
miR-6516 directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6516 | miRNA Mature ID | miR-6516-5p | ||
miRNA Sequence |
UUUGCAGUAACAGGUGUGAGCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 32 |
miR-665 directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-665 | miRNA Mature ID | miR-665 | ||
miRNA Sequence |
ACCAGGAGGCUGAGGCCCCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 33 |
miR-6774 directly targets SLC30A10 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6774 | miRNA Mature ID | miR-6774-5p | ||
miRNA Sequence |
ACUUGGGCAGGAGGGACCCUGUAUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 34 |
miR-6840 directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6840 | miRNA Mature ID | miR-6840-3p | ||
miRNA Sequence |
GCCCAGGACUUUGUGCGGGGUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 35 |
miR-6862 directly targets SLC30A10 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6862 | miRNA Mature ID | miR-6862-5p | ||
miRNA Sequence |
CGGGCAUGCUGGGAGAGACUUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 36 |
miR-6871 directly targets SLC30A10 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6871 | miRNA Mature ID | miR-6871-3p | ||
miRNA Sequence |
CAGCACCCUGUGGCUCCCACAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.